Shell surpassed market expectations with a $7.7bn (£6.1bn) profit in the first three months of the year (REUTERS / Reuters) Shell (SHEL.L) The oil major reported stronger-than-expected first-quarter profit, boosted by higher refining margins and robust oil trading. The company also announced $3.5bn (£2.8bn) of share buybacks. The group reported underlying earnings of $7.7bn (£6.1bn) for the first three months of 2024, down from $9.7bn a year earlier. But the result was 6% higher than earnings in the previous quarter and well ahead of analyst estimates of $6.3bn. Shell CEO Wael Sawan described the results as “another quarter of strong operational and financial performance.” The oil major announced a $3.5bn share buyback program, which it expects to complete over the next three months. Its dividend remains unchanged. ADVERTISEMENT Read more: FTSE 100 LIVE: London higher as Fed leaves interest rates unchanged The company, which handed its shareholders $23bn in payouts last year, had one of its most profitable years on record in 2023 when it reported better than expected profits of more than $28bn for the year. Alexander Kirk, fossil fuel campaigner at Global Witness, said such profits show the energy system simply doesn’t work. “Shell continuing to rake in huge sums of money shows us that huge polluter profits were not a one-off but are the twisted reality of an energy system that benefits climate-wrecking companies to the cost of everyone else.” Apple (AAPL) Apple will announce its second quarter earnings after the US market closes later this Thursday. Investors will be watching for key metrics that shape its stock trajectory. For the March quarter, analysts tracked by FactSet expect Apple to post revenue of $90.5bn, down 4.5% from the year-ago quarter. Analysts expect $1.51 in earnings per share, down a penny from a year earlier. That would equate to a 4.75% year-over-year revenue decline. Wall Street is bracing for what has the potential to be a sizable drop in iPhone sales out of China. According to Counterpoint Research, iPhone sales fell 19% in the quarter. “At this point, expectations are pretty darn low,” Dan Niles, founder of Niles Investment Management, told Yahoo Finance. “Competition from China isn’t going away, they’re late to AI, and unfortunately, you’re paying a pretty high PE multiple at 25 times for a company whose March quarter revenues they guided to is exactly the same as three years ago,” he added. Novo Nordisk (NOVO-B.CO) Europe’s most-valuable company revealed better-than-expected profits for the first three months of the year as it races to boost output of its miracle Wegovy weight-loss drug. The Danish pharmaceutical company reported better than expected quarterly sales of DKr65bn (£7.42bn/$9.3bn), up 24% year on year at constant exchange rates, while net profits jumped 28%t to DKr25bn. The drugmaker is now expecting sales to grow between 19% and 27% in 2024, while operating profits are set to rise as much as 30%, up from an upper limit of 29%. Novo Nordisk raised its profit outlook for this year as it plans to double its investment in manufacturing capacity this year to about $6.4bn (£5.1bn) to meet runaway demand for its weight loss injection. Read more: The UK’s most lucrative regions to downsize The group's shares have risen around 260% since launching Wegovy in the United States in June 2021. Novo Nordisk’s market value of £455bn is now bigger than the entire Danish economy. Standard Chartered (STAN.L) Standard Chartered posted higher-than-expected profits after a boost to income from higher interest rates and a strong performance in its trading business. The emerging markets-focused lender posted a 5.5% increase in its reported pre-tax profit of $1.9bn in the first quarter. This compared with $1.81bn the previous year and beat analyst estimates of $1.4bn. Pre-tax profit in its corporate and investment banking division increased 13%, with its markets and retail businesses also reporting rises of 10% and 8% respectively. “We delivered a strong set of results in the first quarter of 2024, with double-digit growth in income and positive operational leverage,” StanChart chief executive Bill Winters said in the earnings statement. “We remain confident in the delivery of our financial targets and are maintaining our full year 2024 guidance.” Watch: Apple, Novo Nordisk earnings, jobless claims: What to watchAAPL), Novo Nordisk (NVO), Shell (SHEL), ConocoPhillips (COP), Cigna (CI), Coinbase (COIN), Moderna (MRNA), DraftKings (DKNG), Kellanova (K), United States Steel (X), and more.\nOn the economic front, jobless claims for the week ending on April 27 will be released. Economists expect claims to rise to 212,000 from 207,000 the prior week.
\nFor more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime.
\nThis post was written by Nicholas Jacobino","thumbnailUrl":"https://s.yimg.com/uu/api/res/1.2/Ub_rb3Cg2s7eB15uoO2CPw--~B/aD0yMzA0O3c9NDA5NjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2024-05/254b8b90-07f3-11ef-befe-17b19e0b2eb6","duration":"PT46S","contentUrl":"https://video.media.yql.yahoo.com/v1/video/sapi/hlsstreams/90c6b927-5412-3958-aa4b-955e7f1ea5b1.m3u8?site=finance®ion=GB&lang=en-GB&devtype=desktop&src=sapi","embedUrl":"https://uk.finance.yahoo.com/video/apple-novo-nordisk-earnings-jobless-205748069.html?format=embed","identifier":"90c6b927-5412-3958-aa4b-955e7f1ea5b1"} Download the Yahoo Finance app, available for Apple and Android.
Trending tickers: Shell, Apple, Novo Nordisk and Standard Chartered
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...